These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pattern of tissue expression of CA-125 and HE4 in primary epithelial ovarian tumours and correlation with serum CA-125 levels. Devan SM; Pailoor J; Sthaneshwar P; Narayanan V Asian Pac J Cancer Prev; 2013; 14(8):4545-8. PubMed ID: 24083699 [TBL] [Abstract][Full Text] [Related]
3. Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Maines-Bandiera S; Woo MM; Borugian M; Molday LL; Hii T; Gilks B; Leung PC; Molday RS; Auersperg N Int J Gynecol Cancer; 2010 Jan; 20(1):16-22. PubMed ID: 20130498 [TBL] [Abstract][Full Text] [Related]
4. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Shen Y; Li L Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144 [TBL] [Abstract][Full Text] [Related]
5. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients. Li QL; Wang CJ; Qi P; Zhang YX Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining. Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987 [TBL] [Abstract][Full Text] [Related]
7. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma. Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911 [TBL] [Abstract][Full Text] [Related]
8. Expression of REG4 in ovarian mucinous tumors. Huang Q; Chen X; Lu W; Lai M; Lu B Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547 [TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma]. Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients. Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054 [TBL] [Abstract][Full Text] [Related]
11. Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer. Xi QP; Pu DH; Lu WN Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4536-4541. PubMed ID: 29131263 [TBL] [Abstract][Full Text] [Related]
12. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation. Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243 [TBL] [Abstract][Full Text] [Related]
13. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses. Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939 [TBL] [Abstract][Full Text] [Related]
14. LyGDI is a promising biomarker for ovarian cancer. Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer. Fan HY; Duan DM; Liu YF Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099 [TBL] [Abstract][Full Text] [Related]
16. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors. Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169 [TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients. Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A Int J Gynecol Cancer; 2011 Aug; 21(6):1040-7. PubMed ID: 21738039 [TBL] [Abstract][Full Text] [Related]